Table 1 Oncologists responses concerning the clinical utility of NGS multigene analysis in various tumor types
From: Comprehensive tumor molecular profile analysis in clinical practice
Oncologists responses | Tumor histology | ||||||
|---|---|---|---|---|---|---|---|
Lung (%) | Colorectal (%) | Breast (%) | Ovarian (%) | Pancreas (%) | Prostate (%) | Rare/unknown (%) | |
Useful | 60.66 | 65.57 | 45.90 | 65.57 | 50.82 | 50.82 | 85.25 |
Useful in the metastatic setting | 39.34 | 29.51 | 34.43 | 14.75 | 44.26 | 39.34 | 14.75 |
Not useful | 0.00 | 4.92 | 9.84 | 9.84 | 0.00 | 0.00 | 0.00 |
No opinion/response | 0.00 | 0.00 | 9.84 | 9.84 | 4.92 | 9.84 | 0.00 |